|
12.7.2022 |
EN |
Official Journal of the European Union |
L 185/138 |
COMMISSION IMPLEMENTING DECISION (EU) 2022/1200
of 11 July 2022
amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
(notified under document C(2022) 5015)
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Article 259(1), point (c), thereof,
Whereas:
|
(1) |
Highly pathogenic avian influenza (HPAI) is an infectious viral disease in birds and may have a severe impact on the profitability of poultry farming causing disturbance to trade within the Union and exports to third countries. HPAI viruses can infect migratory birds, which can then spread these viruses over long distances during their autumn and spring migrations. Therefore, the presence of HPAI viruses in wild birds poses a continuous threat for the direct and indirect introduction of these viruses into holdings where poultry or captive birds are kept. In the event of an outbreak of HPAI, there is a risk that the disease agent may spread to other holdings where poultry or captive birds are kept. |
|
(2) |
Regulation (EU) 2016/429 establishes a new legislative framework for the prevention and control of diseases that are transmissible to animals or humans. HPAI falls within the definition of a listed disease in that Regulation, and it is subject to the disease prevention and control rules laid down therein. In addition, Commission Delegated Regulation (EU) 2020/687 (2) supplements Regulation (EU) 2016/429 as regards the rules for the prevention and control of certain listed diseases, including disease control measures for HPAI. |
|
(3) |
Commission Implementing Decision (EU) 2021/641 (3) has been adopted within the framework of Regulation (EU) 2016/429 and it lays down disease control measures in relation to outbreaks of HPAI. |
|
(4) |
More particularly, Implementing Decision (EU) 2021/641 provides that the protection, surveillance and further restricted zones established by the Member States following outbreaks of HPAI, in accordance with Delegated Regulation (EU) 2020/687, are to comprise at least the areas listed as protection, surveillance and further restricted zones in the Annex to that Implementing Decision. |
|
(5) |
The Annex to Implementing Decision (EU) 2021/641 was recently amended by Commission Implementing Decision (EU) 2022/1021 (4) following outbreaks of HPAI in poultry or captive birds in the Netherlands that needed to be reflected in that Annex. |
|
(6) |
Since the date of adoption of Implementing Decision (EU) 2022/1021, Belgium has notified the Commission of an outbreak of HPAI in an establishment where poultry or captive birds were kept, located in the Vlaams-Brabant Province of that Member State. |
|
(7) |
In addition, the Netherlands have notified the Commission of a new outbreak of HPAI in an establishment where poultry or captive birds were kept, located in the Noord-Holland Province of that Member State. |
|
(8) |
The competent authorities of Belgium and the Netherlands have taken the necessary disease control measures required in accordance with Delegated Regulation (EU) 2020/687, including the establishment of protection and surveillance zones around those outbreaks. |
|
(9) |
The Commission has examined the disease control measures taken by Belgium and the Netherlands in collaboration with those Member States and it is satisfied that the boundaries of the protection and surveillance zones in Belgium and the Netherlands, established by the competent authorities of those Member States, are at a sufficient distance from the establishments where the outbreaks of HPAI have been confirmed. |
|
(10) |
In the Annex to Implementing Decision (EU) 2021/641, there are currently no areas listed as protection and surveillance zones for Belgium. |
|
(11) |
In order to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade being imposed by third countries, it is necessary to rapidly describe at Union level, in collaboration with Belgium and the Netherlands, the protection and surveillance zones established by those Member State in accordance with Delegated Regulation (EU) 2020/687. |
|
(12) |
Therefore, protection and surveillance zones should be listed for Belgium in the Annex to Implementing Decision (EU) 2021/641. |
|
(13) |
In addition, the areas listed for the Netherlands in the Annex to Implementing Decision (EU) 2021/641 should be amended. |
|
(14) |
Accordingly, the Annex to Implementing Decision (EU) 2021/641 should be amended to update regionalisation at Union level to take account of the protection and surveillance zones duly established by Belgium and the Netherlands in accordance with Delegated Regulation (EU) 2020/687, and the duration of the measures applicable therein. |
|
(15) |
Implementing Decision (EU) 2021/641 should therefore be amended accordingly. |
|
(16) |
Given the urgency of the epidemiological situation in the Union as regards the spread of HPAI, it is important that the amendments to be made to Implementing Decision (EU) 2021/641 by this Decision take effect as soon as possible. |
|
(17) |
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
HAS ADOPTED THIS DECISION:
Article 1
The Annex to Implementing Decision (EU) 2021/641 is replaced by the text set out in the Annex to this Decision.
Article 2
This Decision is addressed to the Member States.
Done at Brussels, 11 July 2022.
For the Commission
Stella KYRIAKIDES
Member of the Commission
(2) Commission Delegated Regulation (EU) 2020/687 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council, as regards rules for the prevention and control of certain listed diseases (OJ L 174, 3.6.2020, p. 64).
(3) Commission Implementing Decision (EU) 2021/641 of 16 April 2021 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (OJ L 134, 20.4.2021, p. 166).
(4) Commission Implementing Decision (EU) 2022/1021 of 27 June 2022 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (OJ L 170, 28.6.2022, p. 85).
ANNEX
‘ANNEX
PART A
Protection zones in the concerned Member States (*1) as referred to in Articles 1 and 2:
|
Member State: Belgium
|
|
Member State: France
|
||||||||||||||||||
|
Member State: The Netherlands
|
||||||||||||||
PART B
Surveillance zones in the concerned Member States (*1) as referred to in Articles 1 and 3:
|
Member State: Belgium
|
|
Member State: Bulgaria
|
||||||||
|
Member State: Germany
|
||||||||||||||||
|
Member State: France
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Member State: Hungary
|
||||||||||||||
|
Member State: the Netherlands
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PART C
Further restricted zones in the concerned Member States (*1) as referred to in Articles 1 and 3a:
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex, references to Member State include the United Kingdom in respect of Northern Ireland.